What is Voicebrook?
Voicebrook specializes in pathology reporting solutions, offering products such as VoiceOver PRO and SynoptIQ eCP designed to streamline anatomic pathology reporting. Their software is engineered to ensure compliance with CAP eCP standards, a critical requirement for modern pathology labs. By reducing errors and improving turnaround times, Voicebrook empowers pathology labs to enhance diagnostic accuracy and operational efficiency. The company's focus on anatomic pathology leaders and seamless integration with existing lab systems positions it as a key innovator in the healthcare technology space, enabling labs to prioritize patient care and diagnostics.
How much funding has Voicebrook raised?
Voicebrook has raised a total of $2.2M across 2 funding rounds:
Debt
$1M
Debt
$1.2M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.2M led by PPP
Key Investors in Voicebrook
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Voicebrook?
The recent major strategic investment signals a pivotal growth phase for Voicebrook. This capital infusion is likely to fuel further development of their pathology reporting solutions, potentially expanding their market reach and enhancing their technological capabilities. The company's commitment to compliance and efficiency suggests a strategic focus on solidifying its position within the anatomic pathology market, possibly through further product innovation or strategic partnerships. Voicebrook's trajectory indicates a strong emphasis on leveraging technology to address critical needs in diagnostic workflows.
See full Voicebrook company page
